Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.

The new prefilled syringe has the same composition but removes the need for reconstitution, providing a more convenient option for health care providers who administer vaccines. According to the ...

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...